483
Zhehai WangZhehai Wang – FDA 483, Oct 18, 2021
Record Details
An FDA inspection of Zhehai Wang, a clinical investigator in Jinan, China, revealed a significant issue regarding the conduct of an investigation. The firm failed to conduct an investigation in accordance with the signed statement of investigator and investigational plan. This indicates a serious deviation from protocol requirements for clinical trials.
- Person
View Company Profile
ID · d82ee499-f371-4126-bdf5-2a32eb233e3b
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.